GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $23,000 | -68.1% | 10,210 | -41.3% | 0.00% | – |
Q2 2019 | $72,000 | -93.0% | 17,384 | -91.3% | 0.00% | -100.0% |
Q1 2019 | $1,026,000 | +1052.8% | 200,724 | +231.1% | 0.00% | – |
Q2 2016 | $89,000 | +1.1% | 60,617 | -1.6% | 0.00% | – |
Q1 2016 | $88,000 | -14.6% | 61,596 | -2.2% | 0.00% | – |
Q4 2015 | $103,000 | -27.0% | 62,985 | +3.9% | 0.00% | – |
Q3 2015 | $141,000 | -39.7% | 60,612 | -29.2% | 0.00% | – |
Q2 2015 | $234,000 | +3.5% | 85,606 | +27.7% | 0.00% | – |
Q1 2015 | $226,000 | -28.5% | 67,037 | -26.5% | 0.00% | – |
Q4 2014 | $316,000 | -14.1% | 91,215 | +24.6% | 0.00% | – |
Q3 2014 | $368,000 | -42.1% | 73,196 | +58.8% | 0.00% | -100.0% |
Q2 2014 | $636,000 | -35.7% | 46,082 | -28.7% | 0.00% | 0.0% |
Q1 2014 | $989,000 | +851.0% | 64,631 | +402.8% | 0.00% | – |
Q4 2013 | $104,000 | – | 12,854 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 169,578 | $276,000 | 0.10% |
Geneos Wealth Management Inc. | 445,200 | $725,000 | 0.05% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $20,000 | 0.01% |
Vivaldi Capital Management LP | 19,261 | $30,000 | 0.01% |
Atria Wealth Solutions, Inc. | 278,700 | $454,281 | 0.01% |
OSAIC HOLDINGS, INC. | 1,302,122 | $2,123,000 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $5,632 | 0.00% |
Ameritas Advisory Services, LLC | 45,302 | $74,000 | 0.00% |
CENTAURUS FINANCIAL, INC. | 20,732 | $34,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 19,255 | $31,000 | 0.00% |